211 – 220 of 333
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
- Contribution to journal › Article
-
Mark
Role of T cells in graft rejection and transplantation tolerance
- Contribution to journal › Scientific review
-
Mark
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off : efficacy, safety and feasibility--an open-label, 6-week study
- Contribution to journal › Article
- 2009
-
Mark
Therapeutic hypothermia for comatose survivors after near-hanging-A retrospective analysis
- Contribution to journal › Article
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
- Contribution to journal › Article
-
Mark
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice
- Contribution to journal › Article
-
Mark
The parametric response map is an imaging biomarker for early cancer treatment outcome
- Contribution to journal › Article
-
Mark
Naturalistic studies - Researching the everyday clinical world
- Contribution to journal › Debate/Note/Editorial
-
Mark
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors
(2009) In Proceedings of the National Academy of Sciences of the United States of America 106(47). p.6-19801
- Contribution to journal › Article
- 2008
-
Mark
Liposarcoma : outcome based on the Scandinavian Sarcoma Group register
- Contribution to journal › Article
